The analysis of the cDC subpopulation composition showed that the proportion of CD5+ DC2s and immature DC progenitor cells increases in patients with moderate severity of COVID-19, and the proportion of CD163–CD14– DC3 decreases during the severe course of the disease. The gene discussed is CD14; the disease is COVID-19.